September 10, 2024 12:39 PM EDTUpdated 01:12 PM
FDA+
Manufacturing

FDA sends warn­ing let­ter to In­di­an drug­mak­er af­ter find­ing glass in in­jec­tions 

Anna Brown

News Reporter

In­di­an gener­ic man­u­fac­tur­er Zy­dus Life­sciences was hit with an FDA warn­ing let­ter on Tues­day af­ter it shipped vi­t­a­min B in­jec­tions con­tain­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck­'s Eli­av Barr on sub­cu­ta­neous Keytru­da, Sum­mit and deal shop­ping

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

BioN­Tech rolls out Phase 2 lung can­cer da­ta as VEGF bis­pecifics take cen­ter stage

Roche out­lines com­mer­cial man­u­fac­tur­ing strat­e­gy for GLP-1/GIP as­sets 

FDA tells on­col­o­gy com­pa­nies how to run mul­ti-re­gion­al can­cer tri­als with a US ap­proval in mind

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times